Related Experiment Video
Updated: May 9, 2026
08:56
Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
[Systemic manifestations of primary sclerosing cholangitis]
Klinicheskaia Meditsina
|July 25, 2013
Summary
Primary sclerosing cholangitis (PSC) frequently co-occurs with other autoimmune conditions. Identifying these systemic manifestations aids in the early diagnosis of PSC, especially in patients with unexplained cholestasis.
Area of Science:
- Hepatology
- Autoimmunology
- Gastroenterology
Background:
- Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease with unknown etiology, often considered autoimmune.
- PSC commonly presents with other autoimmune diseases, affecting over 40 different conditions.
- Systemic manifestations of PSC require further investigation for comprehensive understanding and management.
Purpose of the Study:
- To investigate the diversity and prevalence of systemic manifestations in patients with Primary Sclerosing Cholangitis.
- To determine the frequency of co-occurring autoimmune diseases in PSC patients.
- To highlight the importance of recognizing extrahepatic symptoms for early PSC diagnosis.
Main Methods:
- Retrospective analysis of 93 patients with Primary Sclerosing Cholangitis admitted to Tareev Nephrology Clinic.
- Diagnosis of co-existing autoimmune diseases and systemic manifestations.
- Statistical evaluation of the prevalence and combinations of PSC-associated conditions.
Main Results:
- Autoimmune diseases were diagnosed in 79.6% of the studied PSC patients.
- Most frequent associations included ulcerative colitis (49.5%), Crohn's disease (17.2%), hemorrhagic vasculitis (8.6%), and autoimmune thyroiditis (7.59%).
- Multiple (2-5) systemic manifestations were observed in 20.3% of patients.
Conclusions:
- Primary Sclerosing Cholangitis frequently exhibits diverse systemic and autoimmune manifestations.
- Recognizing these extrahepatic symptoms is crucial for the early diagnosis of PSC in patients with cholestasis of uncertain origin.
- Understanding the spectrum of PSC comorbidities can improve patient management and outcomes.
More Related Videos
Related Concept Videos
01:20Cholecystitis
Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:22Portal Hypertension
Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
01:24Chronic Pancreatitis I: Introduction
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:25Chronic Pancreatitis I: Introduction
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...